ANNOUNCEMENT
Introduction : What is WPI-Bio2Q?
March 25, 2024
Credits: WPI-Bio2Q
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) is the first microbiome research center in Japan and the country’s first private university to be selected by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) as a WPI center in October 2022. It will use both quantum computing and conventional bioanalytical methods to reveal the complex interactions between the microbiome and humans at the molecular level. Aiming for a longevity society, the center hopes to develop new medications and therapies for diseases that have proven difficult to treat.
We welcome your support to promote research at WPI-Bio2Q:
SHARE
More Bio2Q News
[Publication] Highly Selective Cytokine Induction of Nitrated Lipid-Modified α-G...
Title Highly Selective Cytokine Induction of Nitrated Lipid-Modified α-GalCer Derivatives Demonstrating High Binding Affinity to the Lipid ...
[Publication] Heterochromatin-dependent transcription links the PRC2 complex to ...
Title Heterochromatin-dependent transcription links the PRC2 complex to small RNA-mediated DNA elimination Authors Therese Solberg [1...
Professor Michisuke Yuzaki Receives 2024 Uehara Prize
We are pleased to announce that Professor Michisuke Yuzaki, Special Advisor to Director and PI of Bio2Q, has been awarded the "Uehara Memori...
Call for full-time Technical Staff for Professor Nadinath Nillegoda’s Lab
Nadinath Nillegoda’s Lab is currently hiring a technical staff for FY2025. We look forward to receiving applications from candidates with...
New Member - Dr. Daniel Richard Mende
Introducing new member of Bio2Q We are delighted to welcome Dr. Daniel Richard Mende as a PI at Bio-1 Core of Bio2Q. The greeting from ...
